These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35135481)

  • 21. Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.
    Yao L; Xing X; Li Y; Zhang F; Li P; Liang X; Wang P
    J Transl Med; 2022 Jul; 20(1):333. PubMed ID: 35879718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit.
    Qu X; Hua Y; Khan BA
    Cureus; 2023 Sep; 15(9):e45058. PubMed ID: 37829953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.
    Kashihara N; Yamasaki Y; Osonoi T; Harada H; Shibagaki Y; Zhao J; Kim H; Yajima T; Sarai N
    Clin Exp Nephrol; 2021 Feb; 25(2):140-149. PubMed ID: 33098526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum potassium response to single-dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients.
    Lewis H; Stamper B; Yungkurth AC
    Pharmacotherapy; 2024 Jan; 44(1):13-21. PubMed ID: 37475499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Oshima A; Imamura T; Narang N; Kinugawa K
    Clin Cardiol; 2021 Sep; 44(9):1272-1275. PubMed ID: 34263946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potassium-lowering effects of sodium zirconium cyclosilicate in the early post-transplant period.
    Shockey W; Wiegel JJ; Parajuli S; Garg N; Swanson KJ; Mandelbrot DA
    Clin Transplant; 2024 Jan; 38(1):e15156. PubMed ID: 37812572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E; Ruegger M; Dunne I; Sutaria N; Towers WF
    Am J Health Syst Pharm; 2023 Sep; 80(18):1238-1246. PubMed ID: 37335862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait.
    Elsisi GH; Mahmoud MMI; Al-Humood K; Al-Yousef A
    J Med Econ; 2024; 27(1):253-265. PubMed ID: 38318718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium zirconium cyclosilicate in hyperkalemia.
    Packham DK; Rasmussen HS; Lavin PT; El-Shahawy MA; Roger SD; Block G; Qunibi W; Pergola P; Singh B
    N Engl J Med; 2015 Jan; 372(3):222-31. PubMed ID: 25415807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
    Anker SD; Kosiborod M; Zannad F; Piña IL; McCullough PA; Filippatos G; van der Meer P; Ponikowski P; Rasmussen HS; Lavin PT; Singh B; Yang A; Deedwania P
    Eur J Heart Fail; 2015 Oct; 17(10):1050-6. PubMed ID: 26011677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia.
    Yoo N; Song YB; Dubinsky I; Altshuler J
    Ann Pharmacother; 2023 Sep; 57(9):1044-1052. PubMed ID: 36637028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I Study of the Pharmacodynamics and Safety of Sodium Zirconium Cyclosilicate in Healthy Chinese Adults.
    Cheung T; Sun F; Zhao J; Qin Y; Någård M
    Clin Pharmacol Drug Dev; 2022 Mar; 11(3):348-357. PubMed ID: 34997825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia.
    Hoy SM
    Drugs; 2018 Oct; 78(15):1605-1613. PubMed ID: 30306338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
    Schaefer JA; Gales MA
    Ann Pharmacother; 2016 Jun; 50(6):502-10. PubMed ID: 27009290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K).
    Ni Z; Jin H; Lu R; Zhang L; Yao L; Shao G; Zuo L; Qin S; Zhang X; Zhang Q; Yu W; Luo Q; Ren Y; Peng H; Xiao J; Yang Q; Chen Q; Shi Y;
    BMC Nephrol; 2023 Aug; 24(1):233. PubMed ID: 37559023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S; Dubey J; Amatea J; Finnigan N
    Am J Emerg Med; 2023 Mar; 65():59-64. PubMed ID: 36586223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease.
    Li L; Budden J; Quinn CM; Bushinsky D
    J Cardiovasc Pharmacol Ther; 2024; 29():10742484241227580. PubMed ID: 38311939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant-based diet in hyperkalemic chronic kidney disease patients receiving sodium zirconium cyclosilicate: A feasibility clinical trial.
    Avesani CM; Heimbürger O; Rubin C; Sallstrom T; Fáxen-Irving G; Lindholm B; Stenvinkel P
    Am J Clin Nutr; 2024 Jul; ():. PubMed ID: 39032787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K
    Murphy D; Ster IC; Kaski JC; Anderson L; Banerjee D
    BMC Nephrol; 2021 Jul; 22(1):254. PubMed ID: 34229607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.